---
figid: PMC3012004__nihms259273f2
figlink: /pmc/articles/PMC3012004/figure/F2/
number: Fig. 2
caption: Sites of action for inhibitors and shRNAs in the EGFR-PI3K-Akt-mTOR pathway.
  Agents that inhibit the EGFR-PI3K-Akt-mTOR pathway at multiple sites may contribute
  to anticancer effects in malignant glioma. Agents that inhibit only one target within
  the EGFR-PI3K-Akt-mTOR axis generally show only modest efficacy and fail to induce
  appreciable apoptosis. This disappointing efficacy stems in-part from multiple nodes
  of activation in the EGFR-PI3K-Akt-mTOR axis. For example, loss of PTEN activates
  PI3K signaling. A feedback loop between S6K and IRS-1 also lead to PI3K activation.
  Inhibition of the PI3K-Akt-mTOR pathway may also induce autophagy, enabling cancer
  cells to survive some small molecule inhibitors of this pathway
pmcid: PMC3012004
papertitle: 'Targeting the RTK-PI3K-mTOR Axis in Malignant Glioma: Overcoming Resistance.'
reftext: Qi-Wen Fan, et al. Curr Top Microbiol Immunol. ;347:279-296.
pmc_ranked_result_index: '9700'
pathway_score: 0.9622619
filename: nihms259273f2.jpg
figtitle: Sites of action for inhibitors and shRNAs in the EGFR-PI3K-Akt-mTOR pathway
year: ''
organisms: Homo sapiens
ndex: 23870769-deda-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3012004__nihms259273f2.html
  '@type': Dataset
  description: Sites of action for inhibitors and shRNAs in the EGFR-PI3K-Akt-mTOR
    pathway. Agents that inhibit the EGFR-PI3K-Akt-mTOR pathway at multiple sites
    may contribute to anticancer effects in malignant glioma. Agents that inhibit
    only one target within the EGFR-PI3K-Akt-mTOR axis generally show only modest
    efficacy and fail to induce appreciable apoptosis. This disappointing efficacy
    stems in-part from multiple nodes of activation in the EGFR-PI3K-Akt-mTOR axis.
    For example, loss of PTEN activates PI3K signaling. A feedback loop between S6K
    and IRS-1 also lead to PI3K activation. Inhibition of the PI3K-Akt-mTOR pathway
    may also induce autophagy, enabling cancer cells to survive some small molecule
    inhibitors of this pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CG
  - PDK4
  - MTOR
  - PDK1
  - PDK3
  - IRS1
  - PIK3CA
  - PIK3CB
  - MAPKAP1
  - RPTOR
  - AKT2
  - PIK3R6
  - AKT3
  - PDK2
  - AKT1
  - RICTOR
  - MLST8
  - SART3
  - TSC1
  - EGFR
  - PIK3R4
  - PIK3CD
  - PTEN
  - PIK3R3
  - PIK3R5
  - TSC2
  - LY294002
  - BEZ235
  - Ser
  - Thr
  - Rapamycin
  - Cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PDK2
  symbol: PDK2
  source: hgnc_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Rictor
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: TSC1/TSC2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: TSC1/TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
chemicals:
- word: LY294002
  source: MESH
  identifier: C085911
- word: BEZ235
  source: MESH
  identifier: C531198
- word: Ser
  source: MESH
  identifier: D012694
- word: Thr
  source: MESH
  identifier: D013912
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
